我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Is Breast Cancer Treatment in the End of Life Less Aggressive?

Nuno Guerra-Pereira, Fábio Cassiano, Patrícia Gandolfo, Patricia Cortes, Carlos Carvalho and Sofia Braga

There is overuse of palliative systemic therapy in the end of life of breast cancer patients, but the growing awareness of this practice and the emphasis put in quality of end of life care might be shifting this practice. We hypothesized we could observe: more implementation of palliative strategies; less administration of palliative systemic anti-cancer therapy and decreased aggressiveness of cancer care in the end of life. We characterized the shifting trends in use of palliative chemotherapy administration and palliative care approaches in different institutions and times. We selected women that died of breast cancer during six years, from 2007 to 2012, and were treated in a central acute care general hospital and compared it with the breast cancer patients that died in 2003 and were treated in a large cancer center. We analyzed a total of 232 patients: the more recent group has 114 women and the initial cohort has 118. We used descriptive statistics to characterize chemotherapy in the end of life and use of palliative care resources. We showed increased: referral to palliative care inpatient and outpatient teams,referral to outpatient pain clinics,use of palliative radiotherapy and deaths at hospices instead of at acute care hospitals. Chemotherapy is still prolonged until the end of life, notwithstanding we showed a decrease in such practice. Other indicators of agressiveness, namely hospital admissions, have also shown a decrease. We showed there is more integration of multidisciplinary palliative care and less aggressiveness in the treatment of breast cancer patients, namely, decreased use of palliative anti-cancer treatment and decreased acute care hospital admissions. Nonetheless, systemic chemotherapy is still used until too late and the integration of oncology and palliative medicine in the care of breast cancer patients in the end of life is lacking.